ReTo Eco : INFORMATION CONTAINED IN THIS REPORT - Form 6-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Source: marketscreener.com
Stay updated with breaking news from Minimum Stockholder Equity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER...
Item 8.01 Other Information As previously reported, on November 30, 2023, a Nasdaq Hearings Panel provided Vivos Therapeutics, Inc. until March 19, 2024 to regain compliance...